APA (7th ed.) Citation

Perumal, J., Balabanov, R., Balcer, L., Galetta, S., Sun, Z., Li, H., . . . Fox, R. J. (2023). Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Perumal, Jai, Roumen Balabanov, Laura Balcer, Steven Galetta, Zhaonan Sun, Hanyue Li, Danette Rutledge, Robin L. Avila, and Robert J. Fox. Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis. Adis, Springer Healthcare, 2023.

MLA (9th ed.) Citation

Perumal, Jai, et al. Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis. Adis, Springer Healthcare, 2023.